Symmetry Partners, LLC Albemarle Corp Transaction History

Symmetry Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 02, 2024	SELL	$108.73 - $146.89 $452,316 - $611,062	-4,160 Reduced 70.41%	1,748 $230,000
Q4 2023 Jan 02, 2024	BUY	$113.26 - $170.8 $15,516 - $23,399	137 Added 2.37%	5,908 $883,000
Q3 2023 Oct 10, 2023	SELL	$162.63 - $243.44 $12,847 - $19,231	-79 Reduced 1.35%	5,771 $981,000
Q2 2023 Jul 05, 2023	BUY	$172.91 - $232.22 $13,659 - $18,345	79 Added 1.37%	5,850 $1.31 Million
Q2 2022 Jul 11, 2022	SELL	$187.76 - $270.92 $117,162 - $169,054	-624 Reduced 9.76%	5,771 $1.21 Million
Q1 2021 May 03, 2021	BUY	$140.69 - $185.25 $64,858 - $85,400	461 Added 7.77%	6,395 $934,000
Q4 2020 Feb 18, 2021	BUY	$86.73 - $149.91 $143,538 - $248,101	1,655 Added 38.68%	5,934 $875,000
Q3 2020 Nov 03, 2020	BUY	$75.75 - $100.45 $324,134 - $429,825	4,279 New	4,279 $382,000

924

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $10.1B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.